title: Drug-drug interactions affecting fluoroquinolones.
abstract: In a three-week study, the metabolism of the bronchodilator theophylline and its major metabolites formed by C-8 oxidation (1,3-dimethyluric acid) and N-demethylation (3-methylxanthine and 1-methyluric acid) was investigated in two healthy volunteers. Metabolic studies were performed following intravenous infusion of a single 6 mg/kg dose of aminophylline. During Week 1, theophylline was given alone (blank period), and during Weeks 2 and 3 it was given during oral coadministration of ofloxacin and enoxacin, respectively. Dosage of each quinolone was 200 mg twice daily for four days, starting three days prior to the theophylline infusion. During enoxacin coadministration, elimination half-lives of theophylline increased from 8.7 to 17.4 hours and from 6.1 to 12.3 hours, respectively. Total body clearance of theophylline decreased in both volunteers, whereas renal clearance did not alter. From this it was concluded that the decreased elimination results from a reduced metabolic clearance. During enoxacin coadministration, the formation of the metabolites 1-methyluric acid and 3-methylxanthine clearly was decreased, whereas the formation of 1,3-dimethyluric acid was less affected compared with the blank period. Interference with theophylline disposition by enoxacin is based predominantly on inhibition of microsomal N-demethylation. Ofloxacin comedication did not cause a change in the plasma parameters or renal excretion of theophylline and its metabolites compared with the blank period.
authors.affiliation: Department of Pulmonary Diseases, Foundation of Deventer Hospitals, The Netherlands.
authors.forename: G J
authors.initials: GJ
authors.lastname: Wijnands
authors.forename: T B
authors.initials: TB
authors.lastname: Vree
authors.forename: T J
authors.initials: TJ
authors.lastname: Janssen
authors.forename: P J
authors.initials: PJ
authors.lastname: Guelen
mesh_terms: D000328:Adult; D004347:Drug Interactions; D015365:Enoxacin / Q000494:pharmacology*; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000494:pharmacology*; D010084:Oxidation-Reduction; D013806:Theophylline / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014527:Uric Acid / Q000031:analogs & derivatives / Q000378:metabolism; D014970:Xanthines / Q000378:metabolism
chemical_list: D014970:Xanthines; D014527:Uric Acid; C030530:1-methyluric acid; D015365:Enoxacin; D015242:Ofloxacin; D013806:Theophylline; C031274:1,3-dimethyluric acid; C029703:3-methylxanthine